Literature DB >> 25307589

Neurobehavioral, neurologic, and neuroimaging characteristics of fetal alcohol spectrum disorders.

Leila Glass1, Ashley L Ware1, Sarah N Mattson2.   

Abstract

Alcohol consumption during pregnancy can have deleterious consequences for the fetus, including changes in central nervous system development leading to permanent neurologic alterations and cognitive and behavioral deficits. Individuals affected by prenatal alcohol exposure, including those with and without fetal alcohol syndrome, are identified under the umbrella of fetal alcohol spectrum disorders (FASD). While studies of humans and animal models confirm that even low to moderate levels of exposure can have detrimental effects, critical doses of such exposure have yet to be specified and the most clinically significant and consistent consequences occur following heavy exposure. These consequences are pervasive, devastating, and can result in long-term dysfunction. This chapter summarizes the neurobehavioral, neurologic, and neuroimaging characteristics of FASD, focusing primarily on clinical research of individuals with histories of heavy prenatal alcohol exposure, although studies of lower levels of exposure, particularly prospective, longitudinal studies, will be discussed where relevant.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  behavior; brain; cognition; fetal alcohol spectrum disorders (FASD); fetal alcohol syndrome (FAS); neurobehavioral profile; neuroimaging; neuropsychologic effects; prenatal alcohol exposure

Mesh:

Year:  2014        PMID: 25307589     DOI: 10.1016/B978-0-444-62619-6.00025-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  19 in total

1.  Fetal Alcohol Spectrum Disorders: A Case Study.

Authors:  Leila Glass; Sarah N Mattson
Journal:  J Pediatr Neuropsychol       Date:  2017-01-30

2.  Embryonic Ethanol Exposure Affects the Early Development, Migration, and Location of Hypocretin/Orexin Neurons in Zebrafish.

Authors:  Adam D Collier; Viktoriya Halkina; Soe S Min; Mia Y Roberts; Samantha D Campbell; Kaylin Camidge; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2019-07-06       Impact factor: 3.455

Review 3.  Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.

Authors:  Jeffrey R Wozniak; Edward P Riley; Michael E Charness
Journal:  Lancet Neurol       Date:  2019-05-31       Impact factor: 44.182

4.  Patterns of Prenatal Alcohol Use That Predict Infant Growth and Development.

Authors:  Gretchen Bandoli; Claire D Coles; Julie A Kable; Wladimir Wertelecki; Lyubov Yevtushok; Natalya Zymak-Zakutnya; Alan Wells; Irina V Granovska; Alla O Pashtepa; Christina D Chambers
Journal:  Pediatrics       Date:  2019-01-04       Impact factor: 7.124

Review 5.  Hippocampal deficits in neurodevelopmental disorders.

Authors:  Yue Li; Minjie Shen; Michael E Stockton; Xinyu Zhao
Journal:  Neurobiol Learn Mem       Date:  2018-10-12       Impact factor: 2.877

6.  Relationship Between Task-Based and Parent Report-Based Measures of Attention and Executive Function in Children with Fetal Alcohol Spectrum Disorders (FASD).

Authors:  Julia T Mattson; John C Thorne; Sara T Kover
Journal:  J Pediatr Neuropsychol       Date:  2020-06-30

7.  Peroxisome Proliferator-Activated Receptor-γ Agonists: Potential Therapeutics for Neuropathology Associated with Fetal Alcohol Spectrum Disorders.

Authors:  Paul D Drew; Cynthia J M Kane
Journal:  J Clin Cell Immunol       Date:  2016-11-14

8.  Children with Heavy Prenatal Alcohol Exposure Exhibit Atypical Gait Characteristics.

Authors:  Tenille C Taggart; Roger W Simmons; Jennifer D Thomas; Edward P Riley
Journal:  Alcohol Clin Exp Res       Date:  2017-08-21       Impact factor: 3.455

Review 9.  Substance use in pregnancy: The medical challenge.

Authors:  Kerry-Ann Louw
Journal:  Obstet Med       Date:  2018-03-12

Review 10.  Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders.

Authors:  Cynthia J M Kane; Paul D Drew
Journal:  J Neurosci Res       Date:  2020-09-22       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.